{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:41Z","timestamp":1792686461626,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001702","name":"AO Foundation","doi-asserted-by":"publisher","award":["C-11-11-V"],"award-info":[{"award-number":["C-11-11-V"]}],"id":[{"id":"10.13039\/501100001702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"DOI":"10.1007\/s10006-022-01053-2","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T13:04:28Z","timestamp":1649509468000},"page":"263-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Significance of bisphosphonates on angiogenesis in vivo and their effect under geranyl-geraniol addition \u2014 could it alter the treatment of bisphosphonate-associated necrosis of the jaw?"],"prefix":"10.1007","volume":"27","author":[{"given":"Marius","family":"Otto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Weigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3296-7630","authenticated-orcid":false,"given":"Thomas","family":"Ziebart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Lemound","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"issue":"9","key":"1053_CR1","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"1053_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00520-006-0120-z","volume":"15","author":"C Walter","year":"2007","unstructured":"Walter C, Grotz KA, Kunkel M, Al-Nawas B (2007) Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Support Care Cancer 15(2):197\u2013202","journal-title":"Support Care Cancer"},{"issue":"2","key":"1053_CR3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00784-013-1012-5","volume":"18","author":"P Rugani","year":"2014","unstructured":"Rugani P, Luschin G, Jakse N, Kirnbauer B, Lang U, Acham S (2014) Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer. Clin Oral Investig 18(2):401\u2013407","journal-title":"Clin Oral Investig"},{"key":"1053_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1196\/annals.1346.041","volume":"1068","author":"RG Russell","year":"2006","unstructured":"Russell RG (2006) Bisphosphonates: from bench to bedside. Ann N Y Acad Sci 1068:367\u2013401","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 2","key":"1053_CR5","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1007\/s00586-003-0622-z","volume":"12","author":"H Fleisch","year":"2003","unstructured":"Fleisch H (2003) Bisphosphonates in osteoporosis. Eur Spine J 12(Suppl 2):S142\u2013S146","journal-title":"Eur Spine J"},{"key":"1053_CR6","doi-asserted-by":"crossref","unstructured":"Hughes DE, MacDonald BR, Russell RG, Gowen M (1989) Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow. J Clin Invest. [Research Support, Non-U.S. Gov\u2019t] 83(6):1930\u20135","DOI":"10.1172\/JCI114100"},{"key":"1053_CR7","doi-asserted-by":"crossref","unstructured":"Jobke B, Milovanovic P, Amling M, Busse B (2014) Bisphosphonate-osteoclasts: changes in osteoclast morphology and function induced by antiresorptive nitrogen-containing bisphosphonate treatment in osteoporosis patients. Bone. [Research Support, Non-U.S. Gov't] 59:37\u201343","DOI":"10.1016\/j.bone.2013.10.024"},{"issue":"7","key":"1053_CR8","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00784-014-1394-z","volume":"19","author":"AM Pabst","year":"2015","unstructured":"Pabst AM, Kruger M, Ziebart T, Jacobs C, Walter C (2015) Isoprenoid geranylgeraniol: the influence on cell characteristics of endothelial progenitor cells after bisphosphonate therapy in vitro. Clin Oral Investig. 19(7):1625\u20131633","journal-title":"Clin Oral Investig."},{"issue":"5","key":"1053_CR9","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00784-014-1320-4","volume":"19","author":"N Hagelauer","year":"2014","unstructured":"Hagelauer N, Ziebart T, Pabst AM, Walter C (2014) Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation. Clin Oral Investig. 19(5):1079\u20131091","journal-title":"Clin Oral Investig."},{"key":"1053_CR10","doi-asserted-by":"crossref","unstructured":"Koch FP, Yekta SS, Merkel C, Ziebart T, Smeets R (2010) The impact of bisphosphonates on the osteoblast proliferation and Collagen gene expression in vitro. Head Face Med. [Comparative Study In Vitro] 6:12","DOI":"10.1186\/1746-160X-6-12"},{"issue":"1","key":"1053_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00784-009-0266-4","volume":"14","author":"C Walter","year":"2010","unstructured":"Walter C, Klein MO, Pabst A, Al-Nawas B, Duschner H, Ziebart T (2010) Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Investig 14(1):35\u201341","journal-title":"Clin Oral Investig"},{"key":"1053_CR12","unstructured":"Vassiliadou A (2003) Humane Osteoblasten und Bisphosphonate: eine in vitro Studie des Verhaltens von humanen Osteoblasten unter dem Einflu\u00df von Bisphosphonaten verschiedener Generationen: Universit\u00e4tsbibliothek Giessen"},{"key":"1053_CR13","doi-asserted-by":"crossref","unstructured":"Walter C, Pabst A, Ziebart T, Klein M, Al-Nawas B (2011) Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro. Oral Dis. [Comparative Study] 17(2):194\u20139","DOI":"10.1111\/j.1601-0825.2010.01720.x"},{"issue":"1","key":"1053_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00784-009-0365-2","volume":"15","author":"T Ziebart","year":"2011","unstructured":"Ziebart T, Pabst A, Klein MO, Kammerer P, Gauss L, Brullmann D et al (2011) Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro. Clin Oral Investig 15(1):105\u2013111","journal-title":"Clin Oral Investig"},{"key":"1053_CR15","doi-asserted-by":"crossref","unstructured":"Koch FP, Wunsch A, Merkel C, Ziebart T, Pabst A, Yekta SS et al (2011) The influence of bisphosphonates on human osteoblast migration and integrin aVb3\/tenascin C gene expression in vitro. Head Face Med. [In Vitro] 7(1):4","DOI":"10.1186\/1746-160X-7-4"},{"key":"1053_CR16","doi-asserted-by":"crossref","unstructured":"Koch FP, Merkel C, Al-Nawas B, Smeets R, Ziebart T, Walter C et al (2011) Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2. J Craniomaxillofac Surg. [Comparative Study] 39(8):562\u20139","DOI":"10.1016\/j.jcms.2010.10.007"},{"key":"1053_CR17","doi-asserted-by":"crossref","unstructured":"Koch FP, Merkel C, Ziebart T, Smeets R, Walter C, Al-Nawas B (2012) Influence of bisphosphonates on the osteoblast RANKL and OPG gene expression in vitro. Clin Oral Investig. [Comparative Study] 16(1):79\u201386","DOI":"10.1007\/s00784-010-0477-8"},{"key":"1053_CR18","doi-asserted-by":"publisher","unstructured":"Otto M, Lux C, Schlittenbauer T, Halling F, Ziebart T (2021) Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing.\u00a0Oral Maxillofac Surg. https:\/\/doi.org\/10.1007\/s10006-021-00982-8","DOI":"10.1007\/s10006-021-00982-8"},{"issue":"39","key":"1053_CR19","doi-asserted-by":"publisher","first-page":"14537","DOI":"10.1073\/pnas.0604144103","volume":"103","author":"K Sasaki","year":"2006","unstructured":"Sasaki K, Heeschen C, Aicher A, Ziebart T, Honold J, Urbich C et al (2006) Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci USA 103(39):14537\u201314541","journal-title":"Proc Natl Acad Sci USA"},{"key":"1053_CR20","doi-asserted-by":"crossref","unstructured":"Ziebart T, Yoon CH, Trepels T, Wietelmann A, Braun T, Kiessling F et al (2008) Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res. [Research Support, Non-U.S. Gov't] 103(11):1327\u201334","DOI":"10.1161\/CIRCRESAHA.108.180463"},{"issue":"2","key":"1053_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijmm.2012.1005","volume":"30","author":"MA Konerding","year":"2012","unstructured":"Konerding MA, Ziebart T, Wolloscheck T, Wellmann A, Ackermann M (2012) Impact of single-dose application of TGF-beta, copper peptide, stanozolol and ascorbic acid in hydrogel on midline laparatomy wound healing in a diabetic mouse model. Int J Mol Med 30(2):271\u2013276","journal-title":"Int J Mol Med"},{"issue":"2","key":"1053_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.canlet.2014.11.015","volume":"357","author":"GT Liu","year":"2015","unstructured":"Liu GT, Huang YL, Tzeng HE, Tsai CH, Wang SW, Tang CH (2015) CCL5 promotes vascular endothelial growth factor expression and induces angiogenesis by down-regulating miR-199a in human chondrosarcoma cells. Cancer Lett 357(2):476\u2013487","journal-title":"Cancer Lett"},{"issue":"2","key":"1053_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1160\/TH14-01-0002","volume":"113","author":"S Ahmad","year":"2015","unstructured":"Ahmad S, Hewett PW, Fujisawa T, Sissaoui S, Cai M, Gueron G et al (2015) Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation. Thromb Haemost 113(2):329\u2013337","journal-title":"Thromb Haemost"},{"issue":"1","key":"1053_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.thromres.2004.11.003","volume":"116","author":"LC Petersen","year":"2005","unstructured":"Petersen LC, Norby PL, Branner S, Sorensen BB, Elm T, Stennicke HR et al (2005) Characterization of recombinant murine factor VIIa and recombinant murine tissue factor: a human-murine species compatibility study. Thromb Res 116(1):75\u201385","journal-title":"Thromb Res"},{"key":"1053_CR25","unstructured":"Ruggiero SL (2008) Bisphosphonate-related osteonecrosis of the jaws. Compend Contin Educ Dent 29(2):96\u20138, 100\u20132, 4\u20135"},{"issue":"1","key":"1053_CR26","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12020-009-9285-9","volume":"37","author":"A Enjuanes","year":"2010","unstructured":"Enjuanes A, Ruiz-Gaspa S, Peris P, Ozalla D, Alvarez L, Combalia A et al (2010) The effect of the alendronate on OPG\/RANKL system in differentiated primary human osteoblasts. Endocrine 37(1):180\u2013186","journal-title":"Endocrine"},{"issue":"1","key":"1053_CR27","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/j.jss.2012.03.018","volume":"180","author":"J Jin","year":"2013","unstructured":"Jin J, Wang L, Wang XK, Lai PL, Huang MJ, Jin DD et al (2013) Risedronate inhibits bone marrow mesenchymal stem cell adipogenesis and switches RANKL\/OPG ratio to impair osteoclast differentiation. J Surg Res 180(1):e21\u2013e29","journal-title":"J Surg Res"},{"issue":"1\u20132","key":"1053_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.mce.2012.05.002","volume":"361","author":"M Tsubaki","year":"2012","unstructured":"Tsubaki M, Satou T, Itoh T, Imano M, Yanae M, Kato C et al (2012) Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras\/MEK\/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. Mol Cell Endocrinol 361(1\u20132):219\u2013231","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"1053_CR29","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S1543-2912(13)60101-0","volume":"2","author":"N Price","year":"2004","unstructured":"Price N, Lipton A, Jain VK, Ruggiero S (2004) Prevention and management of osteonecrosis of the jaw associated with bisphosphonate therapy. Support Cancer Ther 2(1):14\u201317","journal-title":"Support Cancer Ther"},{"issue":"3","key":"1053_CR30","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00784-013-1060-x","volume":"18","author":"AM Pabst","year":"2014","unstructured":"Pabst AM, Ziebart T, Ackermann M, Konerding MA, Walter C (2014) Bisphosphonates\u2019 antiangiogenic potency in the development of bisphosphonate-associated osteonecrosis of the jaws: influence on microvessel sprouting in an in vivo 3D Matrigel assay. Clin Oral Investig 18(3):1015\u20131022","journal-title":"Clin Oral Investig"},{"issue":"1","key":"1053_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00784-015-1468-6","volume":"20","author":"PJ Voss","year":"2016","unstructured":"Voss PJ, Stoddart MJ, Bernstein A, Schmelzeisen R, Nelson K, Stadelmann V et al (2016) Zoledronate induces bisphosphonate-related osteonecrosis of the jaw in osteopenic sheep. Clin Oral Invest 20(1):31\u201338","journal-title":"Clin Oral Invest"},{"issue":"7","key":"1053_CR32","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jcms.2015.04.020","volume":"43","author":"PJ Voss","year":"2015","unstructured":"Voss PJ, Stoddart M, Ziebart T, Zeiter S, Nelson K, Bittermann G et al (2015) Zoledronate induces osteonecrosis of the jaw in sheep. J Cranio-Maxillofac Surg 43(7):1133\u20131138","journal-title":"J Cranio-Maxillofac Surg"},{"issue":"2","key":"1053_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.tripleo.2011.02.028","volume":"112","author":"F Wehrhan","year":"2011","unstructured":"Wehrhan F, Stockmann P, Nkenke E, Schlegel KA, Guentsch A, Wehrhan T et al (2011) Differential impairment of vascularization and angiogenesis in bisphosphonate-associated osteonecrosis of the jaw-related mucoperiosteal tissue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(2):216\u2013221","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3A","key":"1053_CR34","first-page":"1551","volume":"28","author":"U Backman","year":"2008","unstructured":"Backman U, Svensson A, Christofferson RH, Azarbayjani F (2008) The bisphosphonate, zoledronic acid reduces experimental neuroblastoma growth by interfering with tumor angiogenesis. Anticancer Res 28(3A):1551\u20131557","journal-title":"Anticancer Res"},{"issue":"4","key":"1053_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/01.cad.0000198909.52701.0f","volume":"17","author":"D Ledoux","year":"2006","unstructured":"Ledoux D, Hamma-Kourbali Y, Di Benedetto M, Foucault-Bertaud A, Oudar O, Sainte-Catherine O et al (2006) A new dimethyl ester bisphosphonate inhibits angiogenesis and growth of human epidermoid carcinoma xenograft in nude mice. Anticancer Drugs 17(4):479\u2013485","journal-title":"Anticancer Drugs"},{"issue":"2","key":"1053_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/152581602753658385","volume":"11","author":"T Asahara","year":"2002","unstructured":"Asahara T, Isner JM (2002) Endothelial progenitor cells for vascular regeneration. J Hematother Stem Cell Res 11(2):171\u2013178","journal-title":"J Hematother Stem Cell Res"},{"issue":"10","key":"1053_CR37","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1007\/s00784-019-02806-2","volume":"23","author":"M Otto","year":"2019","unstructured":"Otto M, Blatt S, Pabst A, Mandic R, Schwarz J, Neff A et al (2019) Influence of buffy coat\u2013derived putative endothelial progenitor cells on tumor growth and neovascularization in oral squamous cell carcinoma xenografts. Clin Oral Invest 23(10):3767\u20133775","journal-title":"Clin Oral Invest"},{"issue":"1","key":"1053_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00784-012-0691-7","volume":"17","author":"T Ziebart","year":"2013","unstructured":"Ziebart T, Schnell A, Walter C, Kammerer PW, Pabst A, Lehmann KM et al (2013) Interactions between endothelial progenitor cells (EPC) and titanium implant surfaces. Clin Oral Investig 17(1):301\u2013309","journal-title":"Clin Oral Investig"},{"issue":"5","key":"1053_CR39","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3892\/br.2013.145","volume":"1","author":"T Ziebart","year":"2013","unstructured":"Ziebart T, Ziebart J, Gauss L, Pabst A, Ackermann M, Smeets R et al (2013) Investigation of inhibitory effects on EPC-mediated neovascularization by different bisphosphonates for cancer therapy. Biomed Rep 1(5):719\u2013722","journal-title":"Biomed Rep"},{"issue":"6","key":"1053_CR40","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000347226","volume":"85","author":"D Santini","year":"2013","unstructured":"Santini D, Zoccoli A, Gregorj C, Di Cerbo M, Iuliani M, Pantano F et al (2013) Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting. Oncology 85(6):342\u2013347","journal-title":"Oncology"},{"issue":"1","key":"1053_CR41","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.canlet.2009.06.031","volume":"288","author":"JB Ahn","year":"2010","unstructured":"Ahn JB, Rha SY, Shin SJ, Jeung HC, Kim TS, Zhang X et al (2010) Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients. Cancer Lett 288(1):124\u2013132","journal-title":"Cancer Lett"},{"issue":"9","key":"1053_CR42","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1136\/jcp.2004.016444","volume":"57","author":"W Hilbe","year":"2004","unstructured":"Hilbe W, Dirnhofer S, Oberwasserlechner F, Schmid T, Gunsilius E, Hilbe G et al (2004) CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57(9):965\u2013969","journal-title":"J Clin Pathol"},{"issue":"4","key":"1053_CR43","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3892\/ijmm.2014.1630","volume":"33","author":"M Ackermann","year":"2014","unstructured":"Ackermann M, Pabst AM, Houdek JP, Ziebart T, Konerding MA (2014) Priming with proangiogenic growth factors and endothelial progenitor cells improves revascularization in linear diabetic wounds. Int J Mol Med 33(4):833\u2013839","journal-title":"Int J Mol Med"},{"issue":"3","key":"1053_CR44","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.joms.2006.10.043","volume":"65","author":"FC Senel","year":"2007","unstructured":"Senel FC, Saracoglu Tekin U, Durmus A, Bagis B (2007) Severe osteomyelitis of the mandible associated with the use of non-nitrogen-containing bisphosphonate (disodium clodronate): report of a case. J Oral Maxillofac Surg 65(3):562\u2013565","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"1053_CR45","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/mabi.200300039","volume":"4","author":"H Li","year":"2004","unstructured":"Li H, Wang D, Li S, Liu B, Gao L (2004) Sustained release of BSA from a novel drug delivery matrix \u2013 bullfrog skin collagen film. Macromol Biosci 4(4):454\u2013457","journal-title":"Macromol Biosci"},{"issue":"24","key":"1053_CR46","doi-asserted-by":"publisher","first-page":"245704","DOI":"10.1088\/0957-4484\/19\/24\/245704","volume":"19","author":"D Losic","year":"2008","unstructured":"Losic D, Cole MA, Dollmann B, Vasilev K, Griesser HJ (2008) Surface modification of nanoporous alumina membranes by plasma polymerization. Nanotechnology. 19(24):245704","journal-title":"Nanotechnology."},{"issue":"11","key":"1053_CR47","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0006-2952(00)00243-4","volume":"59","author":"ET Rump","year":"2000","unstructured":"Rump ET, de Vrueh RL, Manoharan M, Waarlo IH, van Veghel R, Biessen EA et al (2000) Modification of the plasma clearance and liver uptake of steroid ester-conjugated oligodeoxynucleotides by association with (lactosylated) low-density lipoprotein. Biochem Pharmacol 59(11):1407\u20131416","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"1053_CR48","first-page":"51","volume":"18","author":"K Pietrucha","year":"1988","unstructured":"Pietrucha K, Kroh J, Antczak J, Zakrzewski S, Rakowski W (1988) Use of low-temperature plasma in the preparation of synthetic polymers for modification by collagen. Polim Med 18(1\u20132):51\u201365","journal-title":"Polim Med"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-022-01053-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10006-022-01053-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-022-01053-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T08:08:12Z","timestamp":1685606892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10006-022-01053-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["1053"],"URL":"https:\/\/doi.org\/10.1007\/s10006-022-01053-2","relation":{},"ISSN":["1865-1569"],"issn-type":[{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All applicable international, national, and institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. A corresponding animal test application (animal experiment G 12\u20131-022) for the experiments was approved by the Landesuntersuchungsamt Rheinland-Pfalz in Koblenz and thus meets all \u00a78 Paragraph 3 (2) of the German Animal Welfare Act required preconditions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"In the present animal study, no declaration of consent was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that no informed consent was needed for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}